Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pekar, M. Ilouze, V. Miller, D. Lipson, S. Ali, J. Bar, A. Onn, D. Shlomi, M. Elimelech, L. Soussan-Gutman, M. Wynes, F. R. Hirsch, N. Peled (Ramat-Gan, Petach Tikva, Israel; Cambridge, Aurora, United States Of America). The art of detecting EML4-ALK gene rearrangements in NSCLC patients – Immediate implications for patient care. Eur Respir J 2013; 42: Suppl. 57, 5095

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic puzzle of ALK rearrangement in lung cancer. A novel intron related abnormality Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Defining a standard set of patient-centered outcomes for patients with lung cancer Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Reducing delays in lung cancer diagnostic pathways to improve patient experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 RT-PCR expression of EML4-ALK oncogene in Bulgarian patients with non-small cell lung cancers Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 An integrated nursing care model for lung cancer patients Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective Year: 2014 Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Novel survey tool used to assess priorities of lung cancer patients and carers Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016